9
Participants
Start Date
February 28, 2014
Primary Completion Date
July 31, 2016
Study Completion Date
July 31, 2016
Palbociclib
Palbociclb will be given at predefined dose level of 75 mg, 100 mg, 125 mg, or 150 mg days 1-14 every 28 days (days 0-14 for cycle 1 only).
Dexamethasone
20 mg by mouth on days 1, 8, 15 and 22 of a 28-day cycle (Day 1 dosing is omitted for cycle 1 only).
Lenalidomide
Lenalidomide at predefined dose level of 5mg, 10 mg, 15 mg, 25 mg daily for days 8-21 (or days 1-21, depending on dose level cohort).
Weill Cornell Medical College, New York
Collaborators (2)
Celgene Corporation
INDUSTRY
Pfizer
INDUSTRY
Weill Medical College of Cornell University
OTHER